Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
T cell bispecific antibodies (TCBs) are the focus of intense development for cancer immunotherapy. Recently, peptide-MHC (major histocompatibility complex)-targeted TCBs have emerged as a new class of biotherapeutics with improved specificity. These TCBs simultaneously bind to target peptides presented by the polymorphic, species-specific MHC encoded by the human leukocyte antigen (HLA) allele present on target cells and to the CD3 coreceptor expressed by human T lymphocytes. Unfortunately, traditional models for assessing their effects on human tissues often lack predictive capability, particularly for “on-target, off-tumor” interactions. Here, we report an immune-infiltrated, kidney organoid-on-chip model in which peripheral blood mononuclear cells (PBMCs) along with nontargeting (control) or targeting TCB-based tool compounds are circulated under flow. The target consists of the RMF peptide derived from the intracellular tumor antigen Wilms’ tumor 1 (WT1) presented on HLA-A2 via a bivalent T cell receptor-like binding domain. Using our model, we measured TCB-mediated CD8 + T cell activation and killing of RMF-HLA-A2-presenting cells in the presence of PBMCs and multiple tool compounds. DP47, a non-pMHC-targeting TCB that only binds to CD3 (negative control), does not promote T cell activation and killing. Conversely, the nonspecific ESK1-like TCB (positive control) promotes CD8 + T cell expansion accompanied by dose-dependent T cell–mediated killing of multiple cell types, while WT1-TCB* recognizing the RMF-HLA-A2 complex with high specificity, leads solely to selective killing of WT1-expressing cells within kidney organoids under flow. Our 3D kidney organoid model offers a platform for preclinical testing of cancer immunotherapies and investigating tissue-immune system interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The findings demonstrated that the TCB could induce cell death in kidney cells expressing the target antigen, with the extent of kidney cell killing dependent on the concentration and duration of TCB exposure.”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Kroll et al., 2023
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Globally optimal stitching of tiled 3D microscopic image acquisitions
Preibisch, S., Saalfeld, S., & Tomancak, P. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp184 · Cited by 2,452
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589
CD69: from activation marker to metabolic gatekeeper
Cibrián, D., & Sánchez‐Madrid, F. (2017) · European Journal of Immunology · doi:10.1002/eji.201646837 · Cited by 948 · cited 2×
“According to the Invitrogen Publication Number MAN0024966 [Revision C0 (32)], the assay workflow is the following: After adding the beads into the flat bottom plate, the beads are washed using a flat magnet and an automated plate washer (405TS microplate washer from Bioteck).”
Flow-enhanced vascularization and maturation of kidney organoids in vitro
Homan, K. A., Gupta, N., Kroll, K. T., Kolesky, D. B., Skylar-Scott, M., Miyoshi, T., Mau, D., Valerius, M. T., Ferrante, T., Bonventre, J. V., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0325-y · Cited by 939
Self-citationNephron organoids derived from human pluripotent stem cells model kidney development and injury
Morizane, R., Lam, A. Q., Freedman, B. S., Kishi, S., Valerius, M. T., & Bonventre, J. V. (2015) · Nature Biotechnology · doi:10.1038/nbt.3392 · Cited by 927
T cell-engaging therapies — BiTEs and beyond
Goebeler, M.-E., & Bargou, R. C. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0347-5 · Cited by 644
Wu, H., Uchimura, K., Donnelly, E. L., Kirita, Y., Morris, S. A., & Humphreys, B. D. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.010 · Cited by 605
Musah, S., Mammoto, A., Ferrante, T. C., Jeanty, S. S. F., Hirano-Kobayashi, M., Mammoto, T., Roberts, K., Chung, S., Novak, R., Ingram, M., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0069 · Cited by 538
Wu, H., Malone, A. F., Donnelly, E. L., Kirita, Y., Uchimura, K., Ramakrishnan, S. M., Gaut, J. P., & Humphreys, B. D. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018020125 · Cited by 417
IL-2– and CD25-dependent immunoregulatory mechanisms in the homeostasis of T-cell subsets
Létourneau, S., Krieg, C., Pantaleo, G., & Boyman, O. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.011 · Cited by 271
Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells
Morizane, R., & Bonventre, J. V. (2017) · Nature Protocols · doi:10.1038/nprot.2016.170 · Cited by 249
T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments
Daver, N., Alotaibi, A. S., Bücklein, V., & Subklewe, M. (2021) · Leukemia · doi:10.1038/s41375-021-01253-x · Cited by 249
Nephrotoxicity and Renal Pathophysiology: A Contemporary Perspective
Barnett, L. M. A., & Cummings, B. S. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy159 · Cited by 240
Drug-Induced Nephrotoxicity: Clinical Impact and Preclinical in Vitro Models
Tiong, H. Y., Huang, P., Xiong, S., Li, Y., Vathsala, A., & Zink, D. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400720w · Cited by 192
Advances in predictive in vitro models of drug-induced nephrotoxicity
Soo, J. Y.-C., Jansen, J., Masereeuw, R., & Little, M. H. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0003-9 · Cited by 191
Targeting the Intracellular WT1 Oncogene Product with a Therapeutic Human Antibody
Dao, T., Yan, S., Veomett, N., Pankov, D., Zhou, L., Korontsvit, T., Scott, A., Whitten, J., Maslak, P., Casey, E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005661 · Cited by 181
Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell Activation
Liu, C. S. C., Raychaudhuri, D., Paul, B., Chakrabarty, Y., Ghosh, A. R., Rahaman, O., Talukdar, A., & Ganguly, D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701118 · Cited by 172
Kmieciak, M., Gowda, M., Graham, L., Godder, K., Bear, H. D., Marincola, F. M., & Manjili, M. H. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-89 · Cited by 167
Walsh, D. A., Borges da Silva, H., Beura, L. K., Peng, C., Hamilton, S. E., Masopust, D., & Jameson, S. C. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900052 · Cited by 165
Kidney organoids: accurate models or fortunate accidents
Little, M. H., & Combes, A. N. (2019) · Genes & Development · doi:10.1101/gad.329573.119 · Cited by 163
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1
Dao, T., Pankov, D., Scott, A., Korontsvit, T., Zakhaleva, V., Xu, Y., Xiang, J., Yan, S., de Morais Guerreiro, M. D., Veomett, N., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3349 · Cited by 162
Rosenfeld, C. S., Cheever, M. A., & Gaiger, A. (2003) · Leukemia · doi:10.1038/sj.leu.2402988 · Cited by 156
Rafiq, S., Purdon, T. J., Daniyan, A. F., Koneru, M., Dao, T., Liu, C., Scheinberg, D. A., & Brentjens, R. J. (2017) · Leukemia · doi:10.1038/leu.2016.373 · Cited by 153
Fluid shear stress enhances T cell activation through Piezo1
Hope, J. M., Dombroski, J. A., Pereles, R. S., Lopez-Cavestany, M., Greenlee, J. D., Schwager, S. C., Reinhart-King, C. A., & King, M. R. (2022) · BMC Biology · doi:10.1186/s12915-022-01266-7 · Cited by 123
Humanized mouse model: a review on preclinical applications for cancer immunotherapy.
Yin, L., Wang, X., Chen, D., Liu, X., & Wang, X. (2020) · American Journal of Cancer Research · Cited by 108
Biomanufacturing human tissues via organ building blocks
Wolf, K. J., Weiss, J. D., Uzel, S. G. M., Skylar‐Scott, M. A., & Lewis, J. A. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.04.012 · Cited by 102
Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA
Holland, C. J., Crean, R. M., Pentier, J. M., de Wet, B., Lloyd, A., Srikannathasan, V., Lissin, N., Lloyd, K. A., Blicher, T. H., Conroy, P. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130562 · Cited by 90
Viallard, J., Blanco, P., André, M., Etienne, G., Liferman, F., Neau, D., Vidal, E., Moreau, J., & Pellegrin, J. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.11.011 · Cited by 83
Mechanism of T lymphocyte activation by OKT3 antibodies. A general model for T cell induction
Landegren, U. D., Andersson, J., & Wigzell, H. (1984) · European Journal of Immunology · doi:10.1002/eji.1830140409 · Cited by 83
Kerns, S. J., Belgur, C., Petropolis, D., Kanellias, M., Barrile, R., Sam, J., Weinzierl, T., Fauti, T., Freimoser-Grundschober, A., Eckmann, J., et al. (2021) · eLife · doi:10.7554/elife.67106 · Cited by 82 · cited 1×
“To address the growing need for human model systems of high predictivity for immuno-oncology (15, 41), we created an immune-infiltrated kidney organoid model that enables the “on target-off tumor” assessment of TCBs in the presence of PBMCs under flow.”
Self-citationThe role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis
Chau, Y.-Y., & Hastie, N. D. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.04.004 · Cited by 78
Bispecific antibodies in haematological malignancies
Viardot, A., & Bargou, R. C. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.04.002 · Cited by 72
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
Augsberger, C., Hänel, G., Xu, W., Pulko, V., Hanisch, L. J., Augustin, A., Challier, J., Hunt, K., Vick, B., Rovatti, P. E., et al. (2021) · Blood · doi:10.1182/blood.2020010477 · Cited by 69
Therapeutic Efficacy of an Fc-Enhanced TCR-like Antibody to the Intracellular WT1 Oncoprotein
Veomett, N. J., Dao, T., Liu, H., Xiang, J., Pankov, D., Dubrovsky, L., Whitten, J. A., Park, S., Korontsvit, T., Zakhaleva, V., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2756 · Cited by 56
Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
Kubiniok, P., Marcu, A., Bichmann, L., Kuchenbecker, L., Schuster, H., Hamelin, D. J., Duquette, J. D., Kovalchik, K. A., Wessling, L., Kohlbacher, O., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103768 · Cited by 47
Gejman, R. S., Jones, H. F., Klatt, M. G., Chang, A. Y., Oh, C. Y., Chandran, S. S., Korontsvit, T., Zakahleva, V., Dao, T., Klebanoff, C. A., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0745 · Cited by 43
Single Cell Sequencing and Kidney Organoids Generated from Pluripotent Stem Cells
Wu, H., & Humphreys, B. D. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07470619 · Cited by 33
Doi, K., Kimura, H., Kim, S. H., Kaneda, S., Wada, T., Tanaka, T., Shimizu, A., Sano, T., Chikamori, M., Shinohara, M., et al. (2023) · Lab on a Chip · doi:10.1039/d2lc00941b · Cited by 27
Jaigirdar, A. A., Rosenberg, S. A., & Parkhurst, M. R. (2016) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000116 · Cited by 24
The physiological interactome of TCR-like antibody therapeutics in human tissues
Marrer‐Berger, E., Nicastri, A., Augustin, A., Kramar, V., Liao, H., Hanisch, L. J., Carpy, A., Weinzierl, T., Durr, E., Schaub, N. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47062-5 · Cited by 21
Growing Kidney Tissue from Stem Cells: How Far from “Party Trick” to Medical Application?
Little, M. H. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.015 · Cited by 18
Marrer‐Berger, E., Nicastri, A., Augustin, A., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1828302/v1 · Cited by 1
Self-citation
Research works printed but not linked: 2
- “ The Wilms’ Tumor (WT1)” in Gene Methods and Protocols, N. Hastie Ed. (Springer Science+Business Media, New York, NY, USA, 2016), vol. 1467, p. 235.
- K. T., Kroll., Dataset for Kroll, Mata, Homan et al. ‘Immune-infiltrated Kidney Organoid-on-Chip Model for Assessing T Cell Bispecific Antibodies’, PNAS, 2023. Materials Data Facility. 10.18126/E8Y5-AYFT. Deposited 24 July 2023. PMC10467620 37603766 · DOI
Cited by
Thorel, L., Perréard, M., Florent, R., Divoux, J., Coffy, S., Vincent, A., Gaggioli, C., Guasch, G., Gidrol, X., Weiswald, L.-B., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01272-5 · Cited by 236
Lymphocytes and innate immune cells in acute kidney injury and repair
Lee, K., Jang, H. R., & Rabb, H. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00875-5 · Cited by 136
Human organoids as 3D in vitro platforms for drug discovery: opportunities and challenges
Wang, D., Villenave, R., Stokar‐Regenscheit, N., & Clevers, H. C. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01317-y · Cited by 130
Wang, Q., Yuan, F., Zuo, X., & Li, M. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02505-w · Cited by 121
Roadblocks confronting widespread dissemination and deployment of Organs on Chips
Alver, C. G., Drabbe, E., Ishahak, M., & Agarwal, A. (2024) · Nature Communications · doi:10.1038/s41467-024-48864-3 · Cited by 74
Metadata
- Authors
- Kroll, K. T., Mata, M. M., Homan, K. A., Micallef, V., Carpy, A., Hiratsuka, K., Morizane, R., Moisan, A., Gubler, M., Walz, A.-C., Marrer-Berger, E., & Lewis, J. A.
- Affiliations
- Harvard University (US)
- F. Hoffmann-La Roche AG (CH)
- Roche Pharma Research and Early Development, Roche Innovation Center Munich, Munich DE-82377, Germany
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel CH-4070, Switzerland
- Corresponding author
- Homan, Kimberly A.
- Lewis, Jennifer A.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2023-08-21
- Volume
- 120
- Issue
- 35
- Pages
- e2305322120-e2305322120
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC10467620
- OpenAlex
- W4386022662
- Cited by
- 79
- References
- 44
- Citations by year
- 2026: 25 · 2025: 26 · 2024: 25 · 2023: 3
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Roche Pharma Research & Early Development (N/A)
- HHS | NIH | National Center for Advancing Translational Sciences (NIH UH3 Grant TR002155)
- International Foundation of Ethical Research (N/A)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- T-cell bispecific antibodies, kidney organoids, organ-on-a-chip, HLA-A2, WT1 peptide, CD8+ T cell activation, T cell-mediated killing, on-target off-tumor toxicity, peripheral blood mononuclear cells, cancer immunotherapy, preclinical drug testing
- MeSH terms
- Humans, Kidney, Leukocytes, Mononuclear, Organoids, HLA-A2 Antigen, Antibodies, Bispecific
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.